Brief: Tongfang Kontafarma Says Unit To Sell 79.83% Of Apros Therapeutics
22/10/2021 15:38
Oct 22 (Reuters) - Tongfang Kontafarma Holdings Ltd
1312.HK :
* TONGFANG KONTAFARMA - UNIT TO SELL 79.83% OF APROS
THERAPEUTICS
& NOVATED LOANS FOR $16 MILLION
Source text for Eikon: ID:nHKSzTKsY
Further company coverage: 1312.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr